Bioactive chromone derivatives - structural diversity

Current Bioactive Compounds

Volumn 6, Issue 2, 2010, Pages 76-89

  Machado, N F L ^a   Marques, M P M ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Anticancer; Chemopreventive; Chemotherapeutic; Chromones; Structure activity relationships (SAR)

Indexed keywords

2 PHENYL CHROMONE; 2 STYRYLCHROMONE; ALOESIN; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BAICALEIN; CAROTENOID; CHROMANONE A; CHROMONE DERIVATIVE; EUGENITINE; EUGENITOL; FLAVOPIRIDOL; HYDROCORTISONE; HYPERIMONE A; HYPERIMONE B; ISOFLAVONE; NIMESULIDE; NOBILETIN; NODULIPREVENONE; PACLITAXEL; POLYPHENOL; RETINOL; STYRYLCHROMONE; TANGERETIN; UNCINOSIDE A; UNCINOSIDE B; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZAPOTIN;

ANTIANGIOGENIC ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL INFECTION; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROTECTION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLON CANCER; COLORECTAL CANCER; DEGENERATIVE DISEASE; DIABETES MELLITUS; DNA FRAGMENTATION; DRUG ACTIVITY; DRUG BINDING; DRUG CONFORMATION; DRUG STRUCTURE; HUMAN; HUNTINGTON DISEASE LIKE SYNDROME; IMMUNOSTIMULATION; LARYNX CANCER; MOUTH CANCER; NONHUMAN; OVARY CANCER; PHARYNX CANCER; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PSYCHOSIS;

EID: 77954071017     PISSN: 15734072     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340710791184859     Document Type: Article

References (149)

1. Riboli, E., Norat, T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am. J. Clin. Nutr., 2003, 78, 559S-569S.
2. Benzie, I.F.F. Evolution of antioxidant defence mechanisms. Eur. J. Nutr., 2000, 39, 53-61.
3. Bravo, L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev., 1998, 56, 317-333.
4. Fresco, P., Borges, F., Diniz, C., Marques, M.P.M. New insights on the anticancer properties of dietary polyphenols. Med. Res. Rev., 2006, 26(6), 747-766.
5. Fresco, P., Borges, F., Marques, M.P.M., Diniz, C. The anticancer properties of dietary polyphenols and its relation with apoptosis. Curr. Pharm. Des., 2010, 16, 114-134.
6. Gomes, C.A., Girao da Cruz, T., Andrade, J.L., Milhazes, N., Borges, F., Marques, M.P.M. Anticancer activity of phenolic acids of natural or synthetic origin: a structure-activity study. J. Med. Chem., 2003, 46, 5395-5401.
7. Graf, B.A., Milbury, P.E., Blumberg, J.B. Flavonols, flavones, flavonones and human health: epidemiological evidence. J. Med. Food, 2005, 8, 281-290.
8. Heijnen, C.G.M., Haenen, G.R.M.M., van Acker, F.A.A., van der Vijgh, W.J.F., Blast, A. Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. Toxicol. In Vitro, 2001, 15, 3-6.
9. Key, T.J., Schatzkin A., Willett, W.C., Allen, N.E., Spencer, E.A., Travis, R.C. Diet, nutrition and the prevention of cancer. Public Health Nutr., 2004, 7, 187-200.
10. Mandalari, G., Tomaino, A., Arcoraci, T., Martorana, M., Turco, V.L., Cacciola, F., Rich, G.T., Bisignano, C., Saija, A., Dugo, P., Cross, K.L., Parker, M. L., Waldron, K.W., Wickham, M. S. J. Characterization of polyphenols, lipids and dietary fibre from almond skins (Amygdalus communis L.). J. Food Compost. Anal., 2010, 23(2), 166-174.
11. Pietta, P.G. Flavonoids as antioxidants. J. Nat. Prod., 2000, 63, 1035-1042.
12. Ren, W., Qiao, Z., Wang, H., Zhu, L., Zhang, L. Flavonoids: promising anticancer agents. Med. Res. Rev., 2003, 23(4), 519-534.
13. Surh, Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer, 2003, 3, 768-780.
14. Swinburn, B. Prevention of cancer. A colossal achievement, with much more to do. Public Health Nutr., 2009, 12, 877-878.
15. Veer, P., Jansen, M.C.J.F., Klerk, M., Kok, F.J. Fruits and vegetables in the prevention of cancer and cardiovascular disease. Public Health Nutr., 1999, 3, 103-107.
16. Harborne, J.B. Classes and functions of secondary products from plants. In Chemicals from Plants - Perspectives on Plant Secondary Products, Walton J.N., Brown D.E., Eds.; Imperial College Press: London, 1999.
17. Haslam, E. Practical Polyphenolics: From Structure to Molecular Recognition and Physiological Action, Cambridge University Press: Cambridge, 1998.
18. Bennardi, D.O., Romanelli, G.P., Jios, J.L., Autino, J.C., Baronetti, G.T., Thomas, H.J. Synthesis of substituted flavones and chromones using a Well-Dawson heteropoly acid as catalyst. ARKIVOC, 2008, (vol. xi), 123-130.
19. Grazul, M., Budzisz, E. Biological activity of metal ion complexes of chromones, coumarins and flavones. Coord. Chem. Rev., 2009, 253, 2588-2598.
20. Li, Y., Fang H., Xu, W. Recent advance in the research of flavonoids as anticancer agents. Mini Rev. Med. Chem., 2007, 7, 663-678.
21. Prasad, K.N., Xie, H., Hao, J., Yang, B., Qiu, S., Wei, X., Chen, F., Jiang, Y. Antioxidant and anticancer activities of 8-hydroxypsoralen isolated from wampee [Clausena lansium (Lour.) Skeels] peel. Food Chem., 2010, 118, 62-66.
22. Recanatini, M., Bisi, A., Cavalli, A., Belluti, F., Gobbi, S., Rampa, A., Valenti, P., Palzer, M., Palusczak, A., Hartmann, R.W. A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17α-hydroxylase/c17,20-lyase. J. Med. Chem., 2001, 44, 672-680.
23. Dillard C.J., German, J.B. Phytochemicals: nutraceuticals and human health. J. Sci. Food Agric., 2003, 80, 1744-1756.
24. Siddiqui, I.A., Saleem, M., Adhami, V.M., Asim M., Mukhtar, H. Tea beverage in chemoprevention and chemotherapy of prostate cancer. Acta Pharmacol. Sin., 2007, 28, 1392-1408.
25. Hsieh, T.C., Wu, J.M. Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin. Anticancer Res., 2009, 29(10), 4025-4032.
26. Garavello, W., Rossi, M., McLaughlin, J.K., Bosetti, C., Negri, E., Lagiou, P., Talamini, R., Franceschi, S., Parpinel, M., Dal Maso L., La Vecchia C. Flavonoids and laryngeal cancer risk in Italy. Ann. Oncol., 2007, 18, 1104-1109.
27. Rossi, M., Garavello, W., Talamini, R., Negri, E., Bosetti, C., Dal Maso, L., Lagiou, P., Tavani, A., Polesel, J., Barzan, L., Ramazzotti, V., Franceschi S., La Vecchia, C. Flavonoids and the risk of oral and pharyngeal cancer: a case-control study from Italy. Cancer Epidemiol. Biomarkers Prev., 2007, 16, 1621-1625.
28. Rossi, M., Negri, E., Lagiou, P., Talamini, R., Dal Maso, L., Montella, M., Franceschi, S., La Vecchia, C. Flavonoids and ovarian cancer risk: a case-control study in Italy. Int. J. Cancer, 2008, 123, 895-898.
29. Rossi, M., Negri, E., Talamini, R., Bosetti, C., Parpinel, M., Gnagnarella, P., Franceschi, S., Dal Maso, L., Montella, M., Giacosa A., La Vecchia, C. Flavonoids and colorectal cancer in Italy. Cancer Epidemiol.Biomarkers Prev., 2006, 15, 1555-1558.
30. Bosetti, C., Bravi, F., Talamini, R., Parpinel, M., Gnagnarella, P., Negri, E., Montella, M., Lagiou, P., Franceschi S., La Vecchia, C. flavonoids and prostate cancer: a study in Italy. Nutr. Cancer, 2006, 56, 123-127.
31. Mink, P.J., Scrafford, C.G., Barraj, L.M., Harnack, L., Hong, C.P., Nettleton J.A., Jacobs, D.R. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am. J. Clin. Nutr., 2007, 85, 895-909.
32. Ostertag, L.M., O'Kennedy, N., Kroon, P.A., Duthie G.G., De Roos, B. Impact of dietary polyphenols on human platelet function - A critical review of controlled dietary intervention studies. Mol. Nutr. Food Res., 2010, 54, 60-81.
33. Manson, M.M. Inhibition of Survival Signaling by Dietary Polyphenols and Indole-3-carbinol. Eur. J. Cancer, 2005, 41, 1842-1853.
34. Manson, M.M. Cancer prevention - the potential for diet to modulate molecular signaling. Trends Mol. Med., 2003, 9, 11-18.
35. Sarkar F.H., Li, Y.W. Cell signaling pathways altered by natural chemopreventive agents. Mutat. Res., 2004, 555, 53-64.
36. Aggarwal, B.B., Takada, Y., Oommen, O.V. From chemoprevention to chemotherapy: common targets and common goals. Exp. Opin. Invest. Drugs, 2004, 13, 1327-1338.
37. Ramos, S. Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways. Mol. Nutr. Food Res., 2008, 52, 507-526.
38. Sarkar, F.H., Li, Y. Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy. Acta Pharmacol. Sin., 2007, 28, 1305-1315.
39. Wu, C.P., Calgano, S.B., Hladky, S.B., Ambudkar S.V., Barrand, M.A. Modulatory effects of plant phenols on human multi-drug resistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J., 2005, 272, 4725-4740.
40. Chemler, J.A., Yan, Y., Leonard E., Koffas, M.A.G. Combinatorial mutasynthesis of flavonoid analogues from acrylic acids in microorganisms. Org. Lett., 2007, 9(10), 1855-1858.
41. Forghieri, M., Laggner, C., Paoli, P., Langer, T., Manao G., Camici C., Bondioli L., Fabio P., Costantino L. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors. Bioorg. Med. Chem., 2009, 17, 2658-2672.
42. Gomes, A., Neuwirth, O., Freitas, M., Couto, D., Ribeiro, D., Figueiredo, A.G.P.R., Silva, A.M.S., Seixas, R.S.G.R., Pinto, D.C.G.A. Synthesis and antioxidant properties of new chromone derivatives. Bioorg. Med. Chem., 2009, 17, 7218-7226.
43. Huang, W., Ding, Y., Miao, Y., Liu, M., Li, Y., Yang, G. Synthesis and antitumor activity of novel dithiocarbamate substituted chromones. Eur. J. Med. Chem., 2009, 44, 3687-3696.
44. Huang, W., Liu, M., Li, Y., Tan, Y., Yang, G. Design, syntheses, and antitumor activity of novel chromone and aurone derivatives. Bioorg. Med. Chem., 2007, 15, 5191-5197.
45. Khan, K.M., Ambreen, M., Hussain S., Perveen S., Choudhari, M.I. Schiff bases of 3-formylchromone as thymidine phosphorylase inhibitors. Bioorg. Med. Chem., 2009, 17, 2983-2988.
46. Kuroda, M., Uchida, S., Watanabe K., Mimaki Y. Chromones from the tubes of Eranthis ciclica and their antioxidant activity. Phytochemistry, 2009, 70, 288-293.
47. Rode, M., Gupta, R.C., Karale B.K., Rindhe, S.S. Synthesis and characterization of some substituted chromones as an antiinfective and antioxidant agents. J. Heterocycl. Chem., 2008, 45, 1597-1602.
48. Tang, H.A., Wang, X.F., Yang, S., Wang, L.F. Synthesis, characterization, and biological activities of Pt(II) and Pd(II) complexes with 2 ',3 ',4 ',5,7-pentahydroxy flavone. Rare Metals, 2004, 23, 38-42.
49. Wang, Q., Yang, Z., Qi G., Qin D. Synthesis, crystal structure, antioxidant activities and DNA-binding studies of the Ln(III) complexes with 7-methoxychromone-3-carbaldehyde-(4'-hydroxy) benzoyl hydrazone. Eur. J. Med. Chem., 2009, 44, 2425-2433.
50. Silva D. Suppression of cancer invasiveness by dietary compounds. Mini Rev. Med. Chem., 2008, 8, 677-688.
51. Cao, G., Sofic, E., Prior, R. L. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationsihps. Free Radic. Biol. Med., 1997, 22, 749-760.
52. Lien, E.S., Ren, S., Bui, H.H., Wang, R. Quantitative structureactivity relationship analysis of phenolic antioxidants. Free Radic. Biol. Med., 1999, 26, 285-294.
53. Deng, Y., Lee, J.P., Tianasoa-Ramamonjy, M., Snyder, J.K., Des Etages, S.A., Kanada, D., Snyder M.P., Turner, C.J. New antimicrobial flavanones from Physena madagascariensis. J. Nat. Prod., 2000, 63, 1082-1089.
54. Ma, W.G., Fuzzati, N., Lu, S.L., Gu S., Hostettmann, K. Further chromones from Eriosema tuberosum. Phytochemistry, 1996, 43, 1339-1343.
55. Fujimoto, H., Nozawa, M., Okuyama E., Ishibashi, M. Five new chromones possessing monoamine oxidase inhibitory activity from an ascomycete, Chaetomium quadrangulatum. Chem. Pharm. Bull., 2002, 50, 330-336.
56. Mazzei, M., Sottofattori, E., Dondero, R., Ibrahim, M., Melloni E., Michetti, M. N,N-Dialkylaminosubstituted chromones and isoxazoles as potential anti-inflammatory agents. Il Farmaco, 1999, 54, 452-460.
57. Motai T., Kitanaka, S. Sesquiterpene chromones from Ferula fukanensis and their nitric oxide production inhibitory effects. J. Nat. Prod., 2005, 68, 1732-1735.
58. Park, M., Kwon, H., Sung, M. Intestinal absorption of aloin, aloeemodin, and aloesin; A comparative study using two in vitro absorption models. Nutr. Res. Pract., 2009, 3, 9-14.
59. Piao, L.Z., Park H.R., Park, Y.K., Lee, S.K., Park J.H., Park, M.K. Mushroom tyrosinase inhibition activity of some chromones. Chem. Pharm. Bull., 2002, 50, 309-311.
60. Gamal-Eldeen, A.M., Djemgou, P.C., Tchuendem, M., Ngadjui, B.T., Tane P., Toshifumi, H. Anti-cancer and immunostimulatory activity of chromones and other constituents from Cassia petersiana. Z. Naturforsch C, 2007, 62, 331-338.
61. Park, J.H., Lee, S.U., Kim, S.H., Shin, S.Y., Lee, J.Y., Shin, C.G., Yoo K.H., Lee, Y.S. Chromone and chromanone derivatives as strand transfer inhibitors of HIV-1 integrase. Arch. Pharmacol. Res., 2008, 31, 1-5.
62. Yu, D., Chen, C.H., Brossi A., Lee, K.H. Anti-AIDS agents 60. Substituted 3'R,4'R-Di-O-(-)-camphanoyl-2',2'-dimethyldihydropyrano[2,3-f]chromone (DCP) analogues as potent anti-HIV agents. J. Med. Chem., 2004, 47, 4072-4082.
63. Mitscher, L.A., Telikepalli, H., McGhee E., Shankel, D.M. Natural antimutagenic agents. Mutat. Res., 1996, 350, 143-152.
64. Conrad, J., Forster-Fromme, B., Constantin, M.A., Ondrus, V., Mika, S., Mert-Balci, F., Klaiber, I., Pfannstiel, J., Moller, W., Rosner, H., Forster-Fromme K., Beifuss, U. Flavonoid glucuronides and a chromone from the aquatic macrophyte Stratiotes aloides. J. Nat. Prod., 2009, 72, 835-840.
65. Ferrari, F., Delle Monache, F., Suarez, A. I., Arvelo, F., Compagnone, R. S. New cytotoxic isoflavone from the root bark of Brosimum utile. Nat. Prod. Res., 2005, 19, 331-335.
66. Nakagawa-Goto, K., Bastow, K. F., Wu, J. H., Tokuda, H. and Lee, K. H. Total synthesis and bioactivity of unique flavone desmosdumotin B and its analogs. Bioorg. Med. Chem. Lett., 2005, 15, 3016-3019.
67. Nomura, M., Tsukada, H., Ichimatsu, D., Ito, H., Yoshida T., Miyamoto, K.I. Inhibition of epidermal growth factor-induced cell transformation by tannins. Phytochmeistry, 2005, 66, 2038-2046.
68. Kumar, S., Singh, B.K., Pandey, A.K., Kumar, A., Sharma, S.K., Raj, H.G., Prasad, A.K., Van der Eycken, E., Parmarb V.S., Ghosh, B. A chromone analog inhibits TNF-a induced expression of cell adhesion molecules on human endothelial cells via blocking NF-jB activation. Bioorg. Med. Chem., 2007, 15, 2952-2962.
69. Semba, S., Itoh, N., Ito, M., harada M., Yamakawa, M. The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenylchromone (ly294002), a specific inhibitor of phosphatidylinositol 3_-kinase, in human colon cancer cells. Clin. Cancer Res., 2002, 8, 1957-1963.
70. Gamal-Eldeen, A.M., Abdel-Lateffand A., Okino, T. Modulation of carcinogen metabolizing enzymes by chromanone A; a new chromone derivative from algicolous marine fungus Penicillium sp. Environ. Toxicol. Pharm., 2009, 28, 317-322.
71. Brusselmans, K., Vrolix, R., Verhoeven G., Swinnen, J.V. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. J. Biol. Chem., 2005, 280, 5636-5645.
72. Duraj, J., Zazrivcova, K., Bodo, J., Sulikova M., Sedlak, J. Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants. Neoplasma, 2005, 52, 273-279.
73. Zhang, S.Z., Yang X.N., Morris, M.E. Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)- mediated transport. Pharmaceut. Res., 2004, 21, 1263-1273.
74. Yoon, J.S., Lee, M.K., Sung S.H., Kim, Y.C. Neuroprotective 2-(2- Phenylethyl)chromones of Imperata cylindrica. J. Nat. Prod., 2006, 69, 290-291.
75. Baziard-Mouysset, G., Younes, S., Labssita, Y., Payard M., Caignard, D., Rettori, M., Renard, P., Pfeiffer, B., Guardiola- Lemaitre, B. Synthesis and structure-activity relationships of novel 2-amino alkyl chromones and related derivatives as CT siteselective ligands. Eur. J. Med. Chem., 1998, 33, 339-347.
76. Chen, I.S., Chang, C.T., Sheen, W.S., Teng, C.M., Tsa, I.L., Duh C.Y., Ko, F.N. Coumarins and antiplatelet aggregation constituents from formosan Peucedanum japonicum. Phytochemistry, 1996, 41, 525-530.
77. Inaba, T., Tanaka, K., Takeno, R., Nagaki, H., Yoshida C., Takano, S. Synthesis and anti-inflammatory activity of 7-methanesulfonylamino- 6-phenoxychromones. antiarthritic effect of the 3-formylamino compound (T-614) in chronic inflammatory cisease models. Chem. Pharm. Bull., 2000, 48, 131-139.
78. Koshy, A.S., Anila L., Vijayalakshmi, N.R. Flavonoids from Garcinia cambogia lower lipid levels in hypercholesterolemic rats. Food Chem., 2001, 72, 289-294.
79. Erickson, R.H., Natalie, K.J., Bock, W., Lu, Z., Farzin, F., Sherrill, R.G., Meloni, D.J., Patch R.J., Rzesotarski, W.J. (Aminoalkoxy) chromones. Selective sigma receptor ligands. J. Med. Chem., 1992, 35, 1526-1535.
80. Peixoto, F., Barros A.I.R.N.A., Silva, A.M.S. Interactions of a new 2-styrylchromone with mitochondrial oxidative phosphorylation. J. Biochem. Mol. Toxicol., 2002, 16, 5220-226.
81. Ueda, J., Imamura, L., Tezuka, Y., Tran, Q.L., Tsudab M., Kadot, S. New sesquiterpene from Vietnamese agarwood and its induction effect on brain-derived neurotrophic factor mRNA expression in vitro. Bioorg. Med. Chem., 2006, 14, 3571-3574.
82. Yagura, T., Ito, M., Kiuchi, F., Honda G., Shimada, Y. Four new 2- (2-Phenylethyl)chromone derivatives from withered wood of Aquilaria sinensis. Chem. Pharm. Bull., 2003, 51, 560-564.
83. Pontius, A., Krick, A., Kehraus, S., Foegen, S.E., Müller, M., Klimo, K., Gerhäuser, C., König, G.M. Noduliprevenone: a novel heterodimeric chromanone with cancer chemopreventive potential. Chemistry, 2008, 14, 9860-9863.
84. Deschamps, J.D., Kenyon V.A., Holman, T.R. Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases. Bioorg. Med. Chem., 2006, 14, 4295-4301.
85. Chen, K.H., Wing, M.S., Lin, J.K. Tangeretin suppresses IL-1betainduced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. Biochem. Pharmacol., 2007, 73(2), 215-727.
86. Depypere H.T., Bracke, M.E., Boterberg, T., Mareel, M., Nuytunck, M., Vennekens K., Serreyn R. Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer. Eur J Cancer, 2000, 36(4), S73.
87. Manthey J.A., Guthrie, N. Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J. Agric. Food Chem., 2002, 50, 5837-5843.
88. Morley, K.L., Ferguson P.J., Koropatnick, J. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Lett., 2007, 251, 168-178.
89. Ohnishi, H., Asamoto, M., Tujimura, K., Hokaiwado, N., Takahashi, S., Ogawa, K., Kuribayashi, M., Ogiso, T., Okuyama H., Shirai, T. Inhibition of cell proliferation by nobiletin, a dietary phytochemical associated with apoptosis and characteristic gene expression, but lack of effect on early rat hepatocarcinogenesis. In Vivo Cancer Sci., 2004, 95, 936-942.
90. Pan, M.H., Chen, W.J., Lin-Shiau, S.Y., Ho, C.T., Lin, J.K. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclindependent kinases 2 and 4 activities as well as elevating Cdk inhibitors P21 and p27 in human colorectal carcinoma cells. Carcinogenesis, 2002, 23, 1677-1684.
91. Yoshimizu, N., Otani, Y., Saikawa, Y., Kubota, T., Yoshida, M., Furukawa, T., Kumai, K., Kameyama, K., Fujii, M., Yano, M., Sato, T., Ito A., Kitajima, M. Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation. Aliment. Pharmacol. Ther., 2004, 20(1), 95-101.
92. Vanhoecke, B.W., Delporte, F., Van Braeckel, E., Heyerick, A., Depyere, H.T., Nuytinck, M., De Keukeleire D., Bracke, M.E. A safety study of oral tangeretin and xanthohumol administration to laboratory mice. In Vivo, 2005, 19, 103-107.
93. Conesa, C.M., Ortega, V.V., Gascon, M.J.Y., Banos, M.A., Jordana, M.C., Benavente-Garcia, O., Castillo, J. Treatment of metastatic melanoma B16F10 by the flavonoids tangeretin, rutin, and diosmin. J. Agric. Food Chem., 2005, 53(17), 6791-6797.
94. Datla, K.P., Christidou, M., Widmer, W.W., Rooprai, H.K., Dexter, D.T. Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. Neuroreport, 2001, 12(17), 3871-3875.
95. Maiti, A., Cuendet, M., Kondratyuk, T., Croy, V.L., Pezzuto J.M., Cushman, M. Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. J. Med. Chem., 2007, 50, 350-355.
96. Budzisz, E. Synthesis, reactions and biological activity of phosphorus-containing derivatives of chromone and coumarin. Phosphorus Sulfur Silicon Relat. Elem., 2004, 10, 2131-2147.
97. Gomes, A. Fernandes, E., Garcia, B.M., Silva, A.M.S., Pinto, D.C.G.A., Santos, C.M.M., Cavaleiro, J.A.S., Lima, J.L.F.C. Cyclic voltammetric analysis of 2-styrylchromones: relationship with the antioxidant activity. Bioorg. Med. Chem., 2008, 16, 7939-7943.
98. Shaw, A.Y., Chang, C.Y., Liau, H.H., Lu, P.J., Chen, H.L., Yang and C.N., Li, H.Y. Synthesis of 2-styrylchromones as a novel class of antiproliferative agents targeting carcinoma cells. Eur. J. Med. Chem., 2009, 44, 2552-2562.
99. Ueda, S. Nakamura, H. Masutani, H. Sasada, T. Takabayashi, A. Yamaoka Y., Yodoi, J. Baicalin induces apoptosis via mitochondrial pathway as prooxidant. Mol. Immunol., 2002, 38, 781-791.
100. Tian B., Hua, Y. Concentration-dependence of prooxidant and antioxidant effects of aloin and aloe-emodin on DNA. Food Chem., 2005, 91, 413-418.
101. An, R.B., Jeong, G.S., Beom, J.S., Sohn D.H., Kim, Y.C. Chromone Glycosides and Hepatoprotective Constituents of Hypericum erectum. Arch. Pharm. Res., 2009, 32, 1393-1397.
102. Yimam, M.A., Zhao, J., Tseng-Crank, J., Brownell, L., Devaraj, S., Jialal, R., Jialal, I., Rockwood, J., Ma, W., Padmapriya, A., Jia, Q. A novel standardized chromone extract (UP780) from Aloe regulated adiponectin production and improved insulin resistance. Planta Med., 2008, 74(9), 926-926.
103. Choi, S., Park, Y.I., Lee, S.K., Kim J.E., Chung, M.H. Aloesin inhibits hyperpigmentation induced by UV radiation. Clin. Exp. Dermatol., 2002, 27, 513-515.
104. Ma, L.Y. Ma, S.C., Wei, F., Lin, R.C., But, P.P.H., Lee S.H.S., Lee, S.F. Uncinoside A and B, Two new antiviral chromone glycosides from Selaginella uncinata. Chem. Pharm. Bull., 2003, 51, 1264-1267.
105. Hutter, J.A., Salman, M., Stavinoha, W.B., Satsangi, N., Williams, R.F., Streeper R.T., Weintraub, S.T. Anti-inflammatory C-glucosyl chromone from Aloe barbadensis. J. Nat. Prod., 1996, 59, 541-543.
106. Surjushe, A., Vasani R., Saple, D.G. Aloe vera: A short review. Indian J. Dermatol., 2008, 53, 163-166.
107. Radka, V., Ahcene, B., Marie, E., Jan K., Ivan, G. Modulation of paclitaxel transport by flavonoid derivatives in human breast cancer cells. Is there a correlation between binding affinity to NBD of Pgp and modulation of transport? Bioorg. Med. Chem., 2006, 14, 4519-4525.
108. Lamson D.W., Brignall, M.S. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern. Med. Rev., 1999, 4, 304-329.
109. Linseisen J., Rohrmann, S. Bioactive Components in Foods - Biomarkers of Dietary Polyphenol Intake for Studying Diet-Cancer Relationships. "Dietary Vitamins, Polyphenols, Selenium and probiotics: Biomarkers of Exposure and Mechanisms of Anticarcinogenic Action, WP9 ECNIS Report - Mechanisms of Modulation of Cancer by Dietary Factors, Akesson, B., Mercke, P., Eds.; Nofer Institute of Occupational Medicine: Lodz, Poland, 2007; pp. 64-70.
110. Manson, M.M. In: Bioactive Components in Foods - Anticarcinogenic Effects of Flavomoids. Dietary Vitamins, Polyphenols, Selenium and Probiotics: Biomarkers of Exposure and Mechanisms of Anticarcinogenic Action, WP9 ECNIS Report - Mechanisms of Modulation of Cancer by Dietary Factors, Akesson, B., Mercke, P., Eds.; Nofer Institute of Occupational Medicine: Lodz, Poland, 2007; pp. 115-122.
111. Sancho, R., Marquez, N., Gomez-Gonzalo, M., Calzado, M.A., Bettoni, G., Coiras, M.T., Alcami, J., Lopez-Cabrera, M., Appendino, G., Munoz, E.J. Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway. Biol. Chem., 2004, 279, 37349-37359.
112. Kelland, L.R. Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status. Exp. Opin. Invest. Drugs, 2000, 9, 2903-2911.
113. Senderowicz, A.M. Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials. Invest. New Drugs, 1999, 17, 313-320.
114. Senderowicz, A.M., Sausville, E.A. Preclinical and clinical development of cyclin-dependent kinase modulators. J. Natl. Cancer Inst., 2000, 92, 376-387.
115. Raju, U., Nakata, E., Mason, K.A., Ang, K.K., Milas, L. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells. Cancer Res., 2003, 63, 3263-3267.
116. Lopez-Lazaro, M. Flavonoids as anticancer agents: structureactivity relationship study. Curr. Med. Chem., 2002, 2, 691-714.
117. Heim, K.E., Tagliaferro A.R., Bobilya, D.J. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem., 2002, 13, 572-584.
118. Samee, W., Sae-Lee N., Ungwitayatorn, J. Structure-radical scavenging activity relationships of the synthesized chromone derivatives. SWU J. Pharm. Sci., 2004, 9, 36-42.
119. Boumendjel, A., Nicolle, E., Moraux, T., Gerby, B., Blanc, M., Ronot, X., Boutonnat, J., Piperazinobenzopyranones and phenalkylaminobenzopyranones: potent inhibitors of breast cancer resistance protein (ABCG2). J. Med. Chem., 2005, 48, 7275-7281.
120. Griffin, R.J., Fontana, G., Golding, B.T., Guiard, S., Hardcastle, I.R., Leahy, J.J.J., Martin, N., Richardson, C., Rigoreau, L., Stockley, M., Smith, G.C.M. Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of dna-dependent protein kinase: synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro. J. Med. Chem., 2005, 48, 569-585.
121. Hadjeri, M., Barbier, M., Ronot, X., Mariotte, A. M., Boumendjel, A., Boutonnat, J. Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues. J. Med. Chem., 2003, 46, 2125-2131.
122. Ishar, M.P.S., Singh, G., Singh, S., Sreenivasan, K.K., Singh, G. Design, synthesis, and evaluation of novel 6-chloro-/fluorochromone derivatives as potential topoisomerase inhibitor anticancer agents. Bioorg. Med. Chem. Lett., 2006, 16, 1366-1370.
123. Kim, Y.W., Hackett, J.C., Brueggemeier, R.W. Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones. J. Med. Chem., 2004, 47, 4032-4040.
124. Kim, K.S., Sack, J.S., Tokarski, J.S., Qian, L., Chao, S.T., Leith, L., Kelly, Y.F., Misra, R.N., Hunt, J.T., Kimball, S.D., Humphreys, W.G., Wautlet, B.S., Mulheron, J.G., Webster, K.R. Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects. J. Med. Chem., 2000, 43, 4126-4134.
125. Lindell, S.D., Ort, O., Lummen, P., Klein, R. The design and synthesis of novel inhibitors of NADH:ubiquinone oxidoreductase. Bioorg. Med. Chem. Lett., 2004, 14, 511-514.
126. Schoepfer, J., Fretz, H., Chaudhuri, B., Muller, L., Seeber, E., Meijer, L., Lozach, O., Vangrevelinghe, E., Furet, P. Structurebased design and synthesis of 2-benzylidene-benzofuran-3-ones as flavopiridol mimics. J. Med. Chem., 2002, 45, 1741-1747.
127. Chen, D., Dou, Q.P. New uses for old copper-binding drugs: converting the pro-angiogenic copper to a specific cancer cell death inducer. Expert Opin. Ther. Targets, 2008, 12(6), 739-748.
128. Cvek B., Dvorak Z.T. Targeting of nuclear factor-κB and proteasome by dithiocarbamate complexes with metals. Curr. Pharm. Des., 2007, 13(30), 3155-3167.
129. Milacic, V., Chen, D., Ronconi, L., Landis-Piwowar, K.R., Fregona D., Dou, Q.P. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26s proteasome in human breast cancer cell cultures and xenografts. Cancer Res., 2006, 66(21), 10478-10486.
130. Zhang, H., Jiu-Sheng W., Peng, F. Potent anticancer activity of pyrrolidine dithiocarbamate-copper complex against cisplatinresistant neuroblastoma cells. Anticancer Drugs, 2008, 19(2), 125-132.
131. Roy, K., Mitra, I. Advances in quantitative structure-activity relationship models of antioxidants. Exp. Opin. Drug Discov., 2009, 4(11), 1157-1175.
132. Cheng, Z., Ren, J., Li, Y., Chang, W., Chen, Z. Study on the multiple mechanisms underlying the reaction between hydroxyl radical and phenolic compounds by quantitative structure and activity relationship. Bioorg. Med. Chem., 2002, 10, 4067-4073.
133. Fang, H., Tong, W., Shi, L.M., Blair, R., Perkins, R., Branham, W., Hass, B.S., Xie, Q., Dial, S.L., Moland C.L., Sheehan, D.M. Structure- activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem. Res. Toxicol., 2001, 142, 280-294.
134. Fiorucci, S., Golebiowski, J., Cabrol-Bass D., Antonczak, S. Oxygenolysis of flavonoid compounds: dft description of the mechanism for quercetin. Chem. Phys. Chem., 2004, 5(11), 1726-1733.
135. Gupta, S., Matthew, S., Abreu, P.M., Aires-de-Sousa, J. QSAR analysis of phenolic antioxidants using MOLMAP descriptors of local properties. Bioor. Med. Chem., 2006, 14, 1199-1206.
136. Reis, M., Lobato, B., Lameira, J., Santos, A.S., Alves, C.N. A theoretical study of phenolic compounds with antioxidant properties. Eur. J. Med. Chem., 2007, 42, 440-446.
137. Selassie, C.D., Kapur, S., Verma R.P., Rosario, M. Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study. J. Med. Chem., 2005, 48, 7234-7242.
138. Amić, D., Davidović-Amić, D., Bešlo, D., Rastija, V., Lǔić B., Trinajstić N. SAR and QSAR of the antioxidant activity of flavonoids. Curr. Med. Chem., 2007, 14, 827-845.
139. Amić, D., Davidović-Amić, D., Bešlo, D., Trinajstić N. Structureradical scavenging activity relationships of flavonoids. Croat. Chem. Acta, 2003, 76, 55-61.
140. Farkas, O., Jakus, J., Héberger, K. Quantitative structure-activity relationship analysis of flavonoid compounds. Molecules, 2004, 9, 1079-1088.
141. Lemańska, K., Szymusiak, H., Tyrakowska, B., Zieliński, R., Soffers, A.E.M.F., Rietjens, I.M.C.M. The influence of pH on antioxidant properties and the mechanism of antioxidant action of hydroxyflavones. Free. Radic. Biol. Med., 2001, 31, 869-881.
142. Ungwitayatorn, J., Samee, W., Pimthon, J. 3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors. J.Mol. Struct., 2004, 689, 99-106.
143. Nunthanavanit, P., Nahoum, G.A., Johnston, B.F., Mackay, S.P., Ungwitayatorn, J. 3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis. Arch. Pharm. Chem. Life Sci., 2008, 341, 357-364.
144. Sadeghipour, M., Terreux R., Phipps, J. Flavonoids and tyrosine nitration: structure-activity relationship correlation with enthalpy of formation. Toxicol. In Vitro, 2005, 19, 155-165.
145. Samee, W., Nunthanavanit P., Ungwitayatorn, J. 3D-QSAR investigation of synthetic antioxidant chromone derivatives by molecular field analysis. Int. J. Mol. Sci., 2008, 9, 235-246.
146. Khlebnikov, A.I., Schepetkin, I.A., Domina, N.G., Kirpotina, L.N., Quinn, M.T. Improved quantitative structure-activity relationship modles to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems. Bioorg. Med. Chem., 2007, 15, 1749-1770.
147. Rice-Evans, C.A., Miller, N.J., Paganga, G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med., 1996, 20, 933-956.
148. Lai H.H., Yen, G.C. Inhibitory effect of isoflavones on peroxynitrite- mediated low-density lipoprotein oxidation. Biosci. Biotechnol. Biochem., 2002, 66, 22-28.
149. Dueñas, M., González-Manzano, S., González-Paramás, A., Santos-Buelga C. Antioxidant evaluation of O-methylated metabolites of catechin, epicatechin and quercetin. J. Pharm. Biomed. Anal., 2010, 51, 443-449.